Formulation and process development of (recombinant human) deoxyribonuclease I as a powder for inhalation

Author： Zijlstra Gerrit S. J. Ponsioen Bart A. Hummel Sylvia Sanders Niek Hinrichs Wouter L.J. de Boer Anne H. Frijlink Henderik W.

Publisher： Informa Healthcare

ISSN： 1083-7450

Source： Pharmaceutical Development and Technology, Vol.14, Iss.4, 2009-08, pp. : 358-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of Formulation and Preparation Process on Ambroxol Hydrochloride Dry Powder Inhalation Characteristics and Aerosolization Properties

By Ren Yachao Yu Chaoqun Meng Kangkang Tang Xing

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 9, 2008-09 ,pp. : 984-991

Informa Healthcare

Access to resources Recommend Favorite

Formulation and Evaluation of Insulin Dry Powder for Inhalation

By Mahesh Kumar T. Misra Ambikanandan

Drug Development and Industrial Pharmacy, Vol. 32, Iss. 6, 2006-06 ,pp. : 677-686

Informa Healthcare

Access to resources Recommend Favorite

Effect of Particle Formulation on Dry Powder Inhalation Efficiency

Current Pharmaceutical Design, Vol. 16, Iss. 21, 2010-07 ,pp. : 2377-2387

Bentham Science Publishers

Access to resources Recommend Favorite

Dry Powder Formulation of Plasmid DNA and siRNA for Inhalation

Current Pharmaceutical Design, Vol. 21, Iss. 27, 2015-01 ,pp. : 3854-3866

Bentham Science Publishers

Access to resources Recommend Favorite

Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle

By de Boer A.H. Le Brun P.P.H. van der Woude H.G. Hagedoorn P. Heijerman H.G.M. Frijlink H.W.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 54, Iss. 1, 2002-07 ,pp. : 17-24

Elsevier

Access to resources Recommend Favorite